diabetes

There are many benefits to maintaining strong metabolic health, including weight management, a strong immune system, and reduced risk for chronic disease. But what does your metabolic health have to do with your sexual health? Ask a Sexpert! In this video, Dr. Taylor Kohn unpacks the impact of...

Carel le Roux is a Professor of Experimental Pathology at University College Dublin, Director of the Metabolic Medicine Group, and one of the world's leading researchers on how the gut communicates with the brain. He completed his PhD at Imperial College London, where he conducted foundational...

, discusses : : . ,

Going back and reading some of the posts here, I am realizing that my diabetes misdiagnosis experience isn't unique. Perhaps this will help someone else... I had to overcome systemic racism in healthcare and egocentric doctors at academic centers, and learn an awful lot about diabetes from...

* we discuss what a recently rolled-out GLP-1 pill, the first of its kind approved for obesity, could mean for the future of weight loss. Drugs known as glucagon-like peptide-1 receptor agonists, colloquially called GLP-1 medications, have gone from relatively obscure diabetes...

In this episode of On the Edge of Breakthrough, host Dr. Monty Pal sits down with Dr. Charles Brenner, an internationally recognized expert in metabolism and the founding Chair of the Department of Diabetes & Cancer Metabolism at City of Hope. Together, they explore the metabolic links between...

https://diabetesjournals.org/diabetes/article/74/Supplement_1/1966-LB/158768/1966-LB-Efficacy-and-Safety-of-Semaglutide-7-2-mg Introduction https://sciencehub.novonordisk.com/congresses/ada2025/Lingvay.html

The two largest-ever NIH-funded, multi-center clinical trials (the Women’s Health Initiative and the Minnesota Coronary Survey) where saturated fats were either reduced or replaced by unsaturated fats, on nearly 54,000 men and women, concluded that saturated fats had no effect on cardiovascular...

Ozempic and similar medications have received widespread attention for the treatment of diabetes and weight loss. There’s also growing research that they may help treat heart disease, sleep apnea, kidney disease, substance use disorder and other conditions. Demand has surged for the medications...

Type I Diabetes Mellitus is a terrible disease causing premature death and morbidity. Micro and macrovascular damage are the main contributing factors to injury. This video reports on an article published in the NEJM. The treatment seems to work but there are some serious adverse events...

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA...

New evidence brings more good news about the unanticipated effects of the GLP-1 receptor agonists.

I just found out about the whole ban on compounded tirzepatide (I been living under a rock apparently). My provider presents these options to me now: Empower Pharmacy (Tirzepatide/Niacinamide) Strive (Tirzepatide/Glycine/B12) Southend Pharmacy (Tirzepatide/B6) Red Rock (Tirzepatide/Glycine) I...

In this episode, Dr. Rena Malik, MD, and Dr. Alexandra Sowa dive into the transformative effects of new obesity medications, highlighting dramatic weight loss results and their profound impact on personal and romantic relationships. They explore both the psychological and social dimensions...

In this episode, hosts discuss the efficacy of MariTide for obesity, a head-to-head comparison of semaglutide vs. tirzepatide, and concerns about GLP-1 agonist compounding. https://www.hcplive.com/view/diabetes-dialogue-exploring-new-horizons-in-incretin-therapy-for-diabetes-and-weight-loss...

We hosted a Virtual Science Writers Conference to address the surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Society experts discussed the importance of prescribing FDA-approved medications to...

Dr. Dandona! *Time doesn’t slow down Dandona. At age eighty, he still conducts two full clinics a week, where he and his fellows see twenty-five to thirty patients. How does he do it? That’s the question we want to ask...

Background Male Hypogonadism is common in Type 2 Diabetes with a prevalence of 40% having symptoms of testosterone deficiency [1]. Testosterone deficiency is associated with reduced Quality of Life (QOL), sexual, physical and psychological health. Furthermore, testosterone deficiency is...

In this episode, Dr. Diane Reidy-Lagunes sits down with MSK’s Dr. Neil Iyengar, a nationally recognized expert on the relationship between obesity, metabolic health, and cancer. Together, they discuss the intriguing connection between a new class of weight loss drugs, called GLP-1 agonists, and...

Today we are joined by Dr. Rahul Mehan, a renowned urologist, who sheds light on the impact of Ozempic on sexual function, particularly in relation to erectile dysfunction. He is also the founder of Snip City, which specializes in vasectomy procedures. Ozempic, a semaglutide-based GLP-1...

* Diabetes can severely impact a man's ability to achieve and maintain an erection, as it damages the blood vessels, nerves, hormones, and erectile tissues required for healthy sexual function * Poorly controlled diabetes causes excess sugar to circulate in the blood, damaging arteries and...

OK, so this is totally based on my own experience… I’ve noticed that I have huge, sudden drops in blood sugar (as much as 140 mg/dL) a few minutes after each hcg sub-q shot. The drops don’t last long though so they’re not a big concern- my glucose stabilizes within an hour or so on its own. But...

Fast Money host Melissa Lee talks with CNBC’s DJ Sixsmith about “Big Shot: The Ozempic Revolution,” which premieres on Thursday, February 29 at 10 pm ET. In this one-hour documentary, CNBC takes a deep dive into the global anti-obesity drug market, exploring the risks people are taking to get...

Diabetes is a prevalent disease, primarily characterized by high blood sugar (hyperglycemia). Significantly higher rates of myocardial dysfunction have been noted in individuals with diabetes, even in those without coronary artery disease or high blood pressure (hypertension). Numerous molecular...

https://www.hcplive.com/view/diabetes-dialogue-diabetes-technology-updates-in-january-2024 In this episode, hosts discuss recent news and updates in diabetes technology from Abbott, Dexcom, and Medtronic in the first half of January 2024. The first half of January 2024 has already seen...

At EASD 2023 in Hamburg, Professor Hugh Jones presents an analysis from the ABCD audit of Testosterone in Men with Type 2 Diabetes, confirming that testosterone replacement therapy does improve glycaemic control. Furthermore, the data showed that HbA1c continues to decrease over time. This was...

Aaron Rand, Bill Brownstein, and Leslie Chesterman discuss weight loss and Ozempic ahead of the upcoming eating binge commonly known as Christmas with Dr. Joe Schwarcz, Director of McGill University's Office for Science and Society which has the mission of separating sense from nonsense.

https://vimeo.com/894561902?share=copy 56:10-1:12:31

https://vimeo.com/894561902?share=copy 44:10-56:10 s

https://vimeo.com/894561902?share=copy 32:40-44:06

https://vimeo.com/894561902?share=copy 18:32-32:26